Figure 9 | Scientific Reports

Figure 9

From: Cell Penetrating Peptide Derived from Human Eosinophil Cationic Protein Decreases Airway Allergic Inflammation

Figure 9

Animal Protocol: Brief summary of study protocol as 6 groups: 1. Control: intranasal PBS day 1–22, 2. cIN: intranasal CPPecp day 1–22, 3. mIT: day 1 and day 8 Der p subcutaneous sensitization + day 15 intra-tracheal Der p, 4. cIN + mIT: cIN day 1–15 + mIT, 5. mIT + cIN: mIT + day 15–22 cIN, 6. cIN + mIT + cIN: cIN day 1–22 + mIT.

Back to article page